Tag: Stock

Strategy Pauses Bitcoin Purchases, Reports No Sales of Stock

admin

Strategy, the largest public Bitcoin (BTC) treasury company, reported no additional purchases of the cryptocurrency last week as many entities are pivoting into alternative methods for revenue. In a Monday filing with the US Securities and Exchange Commission (SEC), Michael Saylor-led Strategy reported that it did not purchase any Bitcoin between March 23 and March 29, nor did the company sell any shares. Strategy reported holding 762,099 BTC as of Sunday, worth more than $51 billion at the time of publication. Source: SEC Typically, Strategy funds its BTC purchases through…

Nasdaq Tokenization May Split Stock Trading Across Markets: TD Securities

admin

Nasdaq’s push to bring tokenization into capital markets could lead to a dual-market structure in which traditional US exchanges operate alongside blockchain-based trading venues, according to TD Securities — a shift that could split trading activity and lead to price differences across platforms. In a recent note, Reid Noch, vice president of US equity market structure at TD Securities, pointed to plans by Nasdaq and the New York Stock Exchange to introduce tokenization into alternative trading systems (ATS), a type of venue that matches buyers and sellers outside traditional exchanges.…

Tom Lee’s Bitmine debuts MAVAN staking, stock advances

admin

Bitmine Immersion Technologies (BMNR), led by Fundstrat Global Advisors’ co-founder Thomas “Tom” Lee, is rolling out its MAVAN staking solution after months of infrastructure preparation. MAVAN, short for Made-in-America Validator Network, is a proprietary staking platform built to dominate institutional Ethereum staking and expand into broader blockchain infrastructure services. It was first teased in late 2025 earnings reports for a Q1 2026 debut. The company reports multi-billion-dollar ETH holdings already staked and expects significant annual staking rewards as it continues deployment. Backed by major investors, Bitmine aims to grow MAVAN into…

Robinhood approves $1.5B buyback as stock nears 55% drop since October high

admin

Robinhood has approved a new $1.5 billion share repurchase program, giving the company more than $1.1 billion of additional capacity as management signals confidence in its strategy and financial strength. The company said it expects to execute the refreshed authorization over about three years, while keeping flexibility to move faster if market conditions allow. The new plan builds on Robinhood’s earlier buyback efforts. The company first launched a $1 billion repurchase program in May 2024, then raised the total authorization by another $500 million in April 2025. By February 2026,…

Circle stock drops nearly 20% as CLARITY Act draft targets stablecoin yield

admin

Circle shares dropped nearly 20% Tuesday, falling toward the $100 level after a CoinDesk report revealed new draft language in the CLARITY Act that would ban yield on stablecoin balances. The proposed rules would prohibit issuers from offering passive rewards for simply holding a stablecoin and restrict structures that resemble interest-bearing deposits. While activity-based rewards may still be allowed, the framework remains unclear, according to people familiar with the draft reviewed by industry participants on Capitol Hill. The update directly affects stablecoin issuers such as Circle. Although USDC does not…

Glider, Ondo Launch Custom Tokenized Stock Portfolios Without Brokers

admin

Glider and Ondo Finance have introduced a platform to let retail investors build and automate custom portfolios of tokenized US stocks, offering direct exposure to equities without a brokerage account. According to the announcement, the platform allows users to create personalized baskets of onchain stocks that track real-world assets, removing the need for wallets, gas fees or manual transaction management. Glider co-founder and CEO Brian Huang told Cointelegraph that unlike traditional exchange-traded funds, which bundle assets into fixed products, the platform lets users construct index-like portfolios with custom weightings that…

Nvidia stock falls below 200-day moving average for first time in a year

admin

Nvidia shares fell below their 200-day moving average after this week’s GTC event failed to revive the stock, even as CEO Jensen Huang projected that the company’s Blackwell and Rubin product lines could help drive as much as $1 trillion in data center revenue through 2027. NVDA 1D Chart + 200-DMA Nvidia was down about 3.5% on the day, trading near $172 and approaching a key support level around $170 that has held since September 2025. The 200-day moving average sits near $178, and Nvidia is on pace to close…

Coinbase unveils 24/7 stock futures for global traders in derivatives push

admin

Coinbase now lets global traders gain continuous, leveraged exposure to major US stocks using perpetual futures, expanding beyond crypto into traditional assets while targeting demand for 24/7 trading. The stock market closes. These don’t. Stock perpetual futures are now live for:$AAPL$MSFT$GOOGL$AMZN$NVDA$META$TSLA$SPY$QQQ Now trading 24/7 for eligible traders outside the US. Read more: https://t.co/EeLpluhtxa pic.twitter.com/AvRN11X9Bh — Coinbase Markets 🛡️ (@CoinbaseMarkets) March 20, 2026 The new product covers seven technology stocks, including Apple, NVIDIA, Tesla, Microsoft, Amazon, Alphabet, and Meta, along with ETF perpetual futures. The contracts settle in USD Coin (USDC),…

Coinbase Launches Stock Perpetual Futures for Non‑US Traders

admin

Coinbase has launched stock perpetual futures for eligible non-US traders, expanding its push to offer round-the-clock access to crypto, equities and prediction markets on a single platform. In a Friday blog post, Coinbase said the product was not available to US persons at the current time, but that it was “working to expand this offering to additional regions in the future.” The new contracts are available on Coinbase Advanced for retail users and Coinbase International Exchange for institutional access, giving offshore clients leveraged, cash-settled exposure to major US equities and…

Alto Neuroscience stock rises as firm secures $120M to advance depression drug

admin

Alto Neuroscience, a clinical-stage biopharmaceutical company focused on neuropsychiatric disorders, has secured $120 million from institutional and accredited investors to advance ALTO-207, a fixed-dose combination targeting treatment-resistant depression. ALTO-207 is a novel therapy for treatment-resistant depression that pairs pramipexole, a dopamine receptor agonist, with ondansetron. The combination is designed to enhance antidepressant effects in patients who have not responded to standard treatments. According to a Monday statement, the financing, led by Commodore Capital, will enable Phase 2b and Phase 3 clinical trials and potentially support a New Drug Application submission…